93 7457 (Glipizide and metformin hydrochloride 5 mg / 500 mg)
Pill imprint 93 7457 has been identified as Glipizide and metformin hydrochloride 5 mg / 500 mg.
Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 5 mg / 500 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 5 mg / 500 mg
- 17.00 mm
- Elliptical / Oval
- Prescription only
ferric oxide red
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|00555-0627||Barr Laboratories Inc|
|00591-3973||Watson Pharmaceuticals, Inc. (now Actavis, Inc)|
Note: Inactive ingredients may vary.
More about glipizide/metformin
- Other brands: Metaglip
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.